Section I: Foundations of biosensing and metabolic disorders
1. Detecting the preclinical window in metabolic disorders: Biomarkers, biosensors, diagnostic challenges, and translational opportunities
2. Multi-omic biomarkers and biosensors for metabolic disorders: Discovery to clinical translation
3. Metabolic biosensing technologies: Biophysical foundations, transduction strategies, and clinical translation
Section II: Emerging biosensing platforms for biomarker detection
4. Nanomaterials for metabolic biosensing: Interfacial biophysics, analytical performance, and clinical translation
5. Microfluidic and paper-based biosensing technologies for metabolic disorders: From sample processing to clinical translation
6. Wearable optical and electrochemical biosensors for continuous metabolic monitoring: Principles, system integration, and clinical translation
Section III: Smart and intelligent biosensing approaches
7. Artificial intelligence and machine learning for metabolic biosensors: From data analytics to clinical deployment
8. Cloud-edge architectures for connected metabolic care: IoMT integration, interoperability, analytics, and lifecycle management
9. Continuous wearable and implantable biosensors for metabolic disorders: From biosensing technologies to clinical translation
Section IV: Applications in early detection of specific metabolic disorders
10. Smart biosensing technologies for diabetes mellitus: From biomarker discovery and sensor design to clinical validation and real-world deployment
11. Multimodal biosensing and continuous phenotyping for obesity and metabolic syndrome: Biomarkers, sensor systems, and clinical translation
12. Translational cardiometabolic biosensing integrating biomarkers, multiplex panels, sensing strategies, and clinical validation
13. Multi-omic biomarkers, biosensing technologies, and precision diagnostics for rare and inherited metabolic disorders
14. Advanced biophysical biosensing strategies for monitoring oxidative stress and inflammation in metabolic disorders
Section V: Translational perspectives and future directions
15. Translating smart biosensors for metabolic health: Regulatory pathways, ethical governance and commercialization strategy